1. Corneal Densitometry After Uneventful Descemet Membrane Endothelial Keratoplasty-5-Year Outcomes
- Author
-
Frank Michael Schroeder, Stylianos Kandarakis, Walter Sekundo, Apostolos Lazaridis, Konstantinos Droutsas, Nikolaos Kappos, and Eleftherios Giallouros
- Subjects
medicine.medical_specialty ,Visual acuity ,genetic structures ,Descemet membrane ,business.industry ,Scheimpflug principle ,Endothelium, Corneal ,Fuchs' Endothelial Dystrophy ,Visual Acuity ,Cell Count ,eye diseases ,Endothelial cell density ,Ophthalmology ,Medicine ,Humans ,sense organs ,medicine.symptom ,business ,Densitometry ,Descemet Membrane ,Descemet Stripping Endothelial Keratoplasty ,Retrospective Studies - Abstract
PURPOSE The purpose of this study is to analyze the course of corneal densitometry (CD), endothelial cell density (ECD), best-corrected visual acuity (BCVA), and central corneal thickness (CCT) 5 years after uneventful Descemet membrane endothelial keratoplasty (DMEK). METHODS Sixty uneventful cases (51 patients) with a minimum follow-up of 5 years were included. CD of various corneal layers (anterior, central, posterior, and total layer) and zones (0-2 mm, 2-6 mm, and 6-10 mm) were measured with Scheimpflug tomography. ECD, BCVA, and CCT were also evaluated. RESULTS Total CD at 0 to 2 mm and 2 to 6 mm zones significantly decreased from 33 ± 10 and 27.8 ± 8 grayscale units (GSU) preoperatively to 21.8 ± 3.1 and 22.2 ± 4.2 GSU at 5 years, respectively (P < 0.001). On the contrary, total CD at the 6 to 10 mm zone significantly increased from 30 ± 8.3 GSU preoperatively to 34.6 ± 7.8 GSU at 5 years (P < 0.001). ECD significantly decreased from 2496 ± 267 cells/mm2 preoperatively to 1063 ± 470 cells/mm2 at 5 years (P < 0.001). Similarly, CCT significantly decreased from 686 ± 109 μm preoperatively to 557 ± 37 μm at 5 years (P < 0.001). Postoperative BCVA was significantly better after DMEK for every examination time point. CONCLUSIONS Despite a slight CD increase at all layers of all corneal zones from the second to the fifth postoperative year, the excellent visual outcome was maintained throughout 5-year follow-up. Thus, DMEK seems to effectively treat corneal endothelial disease in the long term.
- Published
- 2021